Sign In to View Organizational & Contract Pricing
Select a Size
Pricing and availability is not currently available.
About This Item
UNSPSC Code:
12352200
NACRES:
NA.32
Skip To
form
lyophilized powder
Quality Level
color
white
solubility
water, double-distilled: soluble
storage temp.
−20°C
1 of 4
This Item | M6449 | SAB4500949 | ZRB1963 |
|---|---|---|---|
| form lyophilized powder | form lyophilized powder | form buffered aqueous solution | form lyophilized |
| solubility water, double-distilled: soluble | solubility water, double-distilled: soluble | solubility - | solubility - |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. 2-8°C |
| Quality Level 200 | Quality Level 200 | Quality Level 100 | Quality Level 200 |
| color white | color white | color - | color - |
Amino Acid Sequence
Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val
General description
Melanoma-associated antigen recognized by T cells-1 (MART-1), also known as Melan-A, is encoded by the gene mapped to human chromosome 9p24.1.[1] The encoded protein is a hydrophobic transmembrane protein.[2] MART-1 is mainly expressed in skin and retinae melanocytes.[2]
The peptide represents amino acids 27-35 of MART-1 protein that is the melanoma antigen recognized by T cells. This peptide mimics the natural epitope that is presented by T cells in humans with reactivity to melanoma cells.
Biochem/physiol Actions
Physical form
Lyophilized from 0.1% aqueous TFA
Other Notes
Lyophilized from 0.1% TFA in H2O
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Comparative genomic hybridization in a case of melanoma that loses expression of S100, HMB45, Melan A and tyrosinase in metastasis
Guo R, et al.
International Journal of Clinical and Experimental Pathology, 7(1), 468-468 (2014)
María Marcela Barrio et al.
PloS one, 7(7), e40311-e40311 (2012-07-07)
Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells. They have been used in different clinical settings to vaccinate cancer patients. We have previously used gamma-irradiated MART-1 expressing melanoma cells as
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service


